Oct 07, 2021 / NTS GMT
Presentation
Oct 07, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Hiroki Sakai
* Kenji Morishima
Santen Pharmaceutical Co., Ltd. - Corporate Officer & Head of China Product Development Department
* Peter Sallstig
* Reza Haque
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, CEO & Representative Director
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shohei Oda
Morgan Stanley, Research Division - Research Associate
=====================
Santen Pharmaceutical Co Ltd
(OTCPK:SNPHY)
$
10.63
0.01 (0.09%)
Market Cap: 3.71 Bil
Enterprise Value: 3.70 Bil
PE Ratio: 21.47
PB Ratio: 1.99
GF Score: 76/100 Santen Pharmaceutical Co Ltd Product Invention Presentation Transcript
Oct 07, 2021 / NTS GMT
Release Date Price:
$13.56
(-0.07%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot